Fact CheckerSign in

NCT06793319Completed

The Effect of Education Given to Patients with Atrial Fibrillation on Anxiety Levels

Atriyal Fibrilasyonu Olan Hastalara Verilen Eğitimin Anksiyete Düzeyleri Üzerine Etkisi

Source: ClinicalTrials.gov · Last updated 27 Jan 2025

Brief summary (registry, in English)

This study aims to evaluate the effect of a structured training program on state anxiety levels in patients diagnosed with Atrial Fibrillation (AF). AF is a chronic heart rhythm disorder that negatively affects patients' quality of life with both physical and psychological symptoms. Lack of information and uncertainty in AF patients cause increased anxiety levels, making compliance with treatment difficult. This study aims to determine whether an educational intervention for AF patients can reduce their anxiety levels and increase their awareness of the disease. This is a randomized controlled trial. A two-session individual training program containing detailed information about AF will be applied to the training group and no training will be given to the control group. Data will be collected through a personal information form and the Situationality Anxiety Inventory (STAI). Hypotheses of the Research H0: Training regarding Atrial Fibrillation has no effect on the anxiety level of patients. H1: Education regarding Atrial Fibrillation reduces the anxiety level of patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
28 Dec 2024
Start date
1 Jul 2024
Primary completion date
31 Oct 2024
Lead sponsor
Kübra Kocaispir
NCT number
NCT06793319

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jul 2024 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • \* Using any psychotropic medication (antidepressant, anxiolytic, antipsychotic)

Who the study is looking for

  • Newly diagnosed with AF,
  • Able to speak and understand Turkish,
  • Does not have a physical or psychological disorder that would cause communication problems,
  • Patients between the ages of 18 and 65 who are oriented to place and time, -Agreeing to participate in the study

Age in the registry: 18 months to 65 months · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Uskudar University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.